Identification of a chemoprevention cohort from a population of women at high risk for breast cancer

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 112-122

  Fabian, Carol J ^a,c   Kamel, Sahar ^a   Zalles, Carola ^b   Kimler, Bruce F ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

biomarkers; breast cancer; chemoprevention; high risk

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROTEIN P53; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ADULT; ANEUPLOIDY; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; CANCER PREVENTION; CANCER RISK; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; POPULATION RISK; PRIORITY JOURNAL; RECEPTOR BINDING; RISK ASSESSMENT; BREAST; BREAST TUMOR; CHEMISTRY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COHORT ANALYSIS; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PILOT STUDY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; ANEUPLOIDY; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CHEMOPREVENTION; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030337954     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1996)25+<112::AID-JCB16>3.0.CO;2-Q     Document Type: Article

References (38)

1. Mulshine JL, Jett M, Cuttitta F, Treston AM, Quinn K, Scott F, Iwai N, Avis I, Linnoila RI, Shaw GL (1993): Scientific basis for cancer prevention. Intermediate cancer markers. Cancer 72 (Suppl):978-983.
2. Kelloff GJ, Boone CW, Steele VE, Fay JR, Lubet RA, Crowell JA, Sigman CC (1994): Mechanistic considerations in chemopreventive drug development. J Cell Biochem 20 (Suppl):1-24.
3. Goodman GE (1992): The clinical evaluation of cancer chemoprevention agents: Defining and contrasting phase I, II, and III objectives. Cancer Res 52 (Suppl): 2752s-2757s.
4. Freedman LS, Schatzkin A, Shiffman MH (1992): Statistical validation of intermediate markers of precancer for use as endpoints in chemoprevention trials. J Cell Biochem 16G (Suppl):27-32.
5. Dupont WD, Page DL (1985): Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:145-151.
6. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W (1994): A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 226:66-71.
7. Marshall CJ, Schumann GB, Ward JH, Riding JM, Cannon-Albright L, Skolnick M (1991): Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer. Am J Clin Pathol 95:157-165.
8. Skolnick MN, Cannon-Albright LA (1992): Genetic predisposition to breast cancer. Cancer 70:1747-754.
9. Millikan R, Hulka B, Thor A, Zhang Y-C, Edgerton S, Zhang X-X, Pei H, He M, Wold L, Melton LJ, Ballard D, Conway K, Liu ET (1995): p53 mutations in benign breast tissue. J Clin Oncol 13:2293-2300.
10. Baylin SB, Herman JG, Wales MM, Vertino P, Wu J, Kurbitz S, Issa JP (1995): Hypermethylation of CpG islands and inactivation of tumor suppressor genes. Proc Am Assoc Cancer Res 36:691.
11. Whittaker JL, Walker RA, Varley JM (1986): Differential expression of cellular oncogenes in benign and malignant human breast tissue. Int J Cancer 38:651-655.
12. Athanassiadou PP, Veneti SZ, Kyrkou KA, Intzes KS, Mouzaka LI, Papadimitriou GK (1992): Presence of epidermal growth factor receptor in breast smears of cyst fluids: Relationship to electrolyte ratios and pH concentration. Cancer Detect Prev 16:113-118.
13. Tsutsumi Y, Naber SP, DeLellis RA, Wolfe HJ, Marks PJ, Mckenzie SJ, Yin S (1990): neu Oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Hum Pathol 21:750-758.
14. Khan SA, Rogers MAM, Obando JA, Tamsen A (1994): Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 57:993-997.
15. Martino S, Ensley JF, Weaver D, Benitez P, An T, Maciorowski Z, De Braud F, Hassan M, Kukuruga M, Signhakowinta A, Valeriote F (1989): Cellular DNA content characteristics of needle aspirates from patients at high-risk for developing breast cancer. Proc Am Assoc Cancer Res 30:256.
16. Visscher DW, Mieale MA, Crissman JD (1993): Pathological and biological relevance of cytophotometric DNA content to breast carcinoma genetic progression. J Cell Biochem 17G (Suppl):114-122.
17. Boone CW, Kelloff GJ (1993): Intraepithelial neoplasia, surrogate endpoint biomarkers and cancer chemoprevention. J Cell Biochem 17F (Suppl):37-48.
18. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schair C, Mulvihill JJ (1989): Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886.
19. Pike MC, Spicer DW (1993): The chemoprevention of breast cancer by reducing sex steroid exposure: Perspectives from epidemiology. J Cell Biochem 17G (Suppl):26-36
20. Fabian CJ, Zalles C, Kamel S, Kimler BF, McKittrick R, Trainin AS, Zeiger S, Moore WP, Hassanein RS, Simon C, Johnson N, Vergara G, Jewell WR, Lin F, Bhatia P, Chin T (1994): Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high- and low risk for breast cancer. Breast Cancer Res Treat 30:263-274.
21. Zalles C, Kimler BF, Kamel S, McKittrick R, Fabian CJ (1995): Cytologic patters in random aspirates from women at high- and low risk for breast cancer. Breast J 1:343-349.
22. Oertel YC (1987): Atypical ductal hyperplasia. In Oertel YC (ed): "Fine Needle Aspiration of the Breast." Stoneham, MA: Butterworths, pp 94-103.
23. Kline TS, Kline IK (1989): High risk lesion. In Kline TS (ed): "Guides to Clinical Aspiration Biopsy." New York: Igaku-Shoin, pp 235-248.
24. Masood S, Frykberg ER, McLellan GL, Scalapino MC, Mitchum DG, Bullard JB (1990): Prospective evaluation of radiologically directed fine-needle aspiration biopsy of nonpalable breast lesions. Cancer 66:1480-1487.
25. Pearson ES, Hartley HO (eds) (1970): "Biometrika Tables for Statisticians," 3rd ed., Vol. 1. Cambridge, MA: Cambridge University Press.
26. Dillon WR, Goldstein M (1984): "Multivariate Analysis Methods and Application." New York: John Wiley and Sons.
27. Pedhazur EJ (1984): "Multiple Regression in Behavior Research," 2nd ed. New York: Holt, Rinehart and Winston.
28. Meyers JL (1979): "Fundamentals of Experimental Design," 3rd ed. Boston, MA: Allyn and Bacon, pp 298-300
29. Ford D, Easton DF, Peto J (1995): Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57:1457-1462.
30. Masood S (1995): Cytomorphology of fibrocystic change, high-risk, and premalignant breast lesions. Breast J 1:210-221.
31. Grizzle WE, Myers RB, Arnold MM, Srivastava S (1994): Evaluation of biomarkers in breast and prostate cancer. J Cell Biochem 19:259-266.
32. King EB, Chew KL, Hom JD, Duarte LA, Mayall B, Miller TR, Neuhaus JM, Wrensch MR Petrakis NL (1991): Characterization by image cytometry of duct epithelial proliferative disease of the breast. Mod Pathol 4:291-296.
33. King EB, Chew KL, Duarte L, Hom JD, Mayall BH, Miller TR, Petrakis NL (1988): Image cytometric classification of premalignant breast disease in fine needle aspirates. Cancer 62:114-124.
34. Van Diest PJ, Baak JPA (1993): Diagnostic and prognostic implications of morphometry and DNA cytometry in breast cytology. In Mouriquand J (ed): "Diagnosis of Non-palpable Breast Lesions: Ultrasonographically Controlled Fine Needle Aspiration." New York: Karger, pp 43-53.
35. Mouriquand J, Bouchet Y, Sage JC, Mermet MA, Ecochard R, Parsi B, Van Diest PJ (1993): Cytoprognostic classification of breast carcinomas: Its predictive value. In Mouriquand J (ed): "Diagnosis of Non-palpable Breast Lesions: Ultrasonographically Controlled Fine Needle Aspiration." New York: Karger, pp 37-42.
36. Bacus JW, Bacus JV (1994): Quality control in image cytometry: DNA ploidy. J Cellular Biochem 19 (Suppl): 153-164.
37. Bacus JW, Bacus JV (1994): A method of correcting DNA ploidy measurements in tissue sections. Mod Pathol 7:652-664.
38. Dawson AE, Cibas ES, Bacus JW, Weinberg DS (1993): Chromatin texture measurement by markovian analysis. Use of nuclear models to define and select texture features. Anal Quant Cytol Histol 15:227-235.